PharmEasy parent to acquire 66% stake in Thyrocare for ₹4,546 cr thehindu.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from thehindu.com Daily Mail and Mail on Sunday newspapers.
Read more about Healthcare shares rise on Business Standard. Healthcare stocks were trading in the positive zone, with the S&P BSE Healthcare index rising 263.67 points or 1.06% at 25160.96 at 09:50 IST.
ICICI Securities has reduce call on
Thyrocare Technologies with a target price of Rs 985. The current market price of Thyrocare Technologies Ltd. is Rs 1043.25.
Thyrocare Technologies Ltd., incorporated in the year 2000, is a Mid Cap company (having a market cap of Rs 5627.95 Crore) operating in Hospitals & Allied Services sector.
Financials For the quarter ended 31-03-2021, the company reported a Consolidated Total Income of Rs 150.48 Crore, up 6.84 % from last quarter Total Income of Rs 140.85 Crore and up 45.39 % from last year same quarter Total Income of Rs 103.50 Crore. Company reported net profit after tax of Rs 37.57 Crore in latest quarter.
The brokerage raises the revenue and EBITDA estimates for FY22E-FY23E by 4-5% and 1-2% to factor in higher revenue from COVID-19 tests as well as its associated expenses. Considering the recent rally in the stock price we downgrade to REDUCE from Hold with a revised DCF-based target of Rs985/share, implying 30.5xFY23E earnings and
Thyrocare Technologies - Margins subdued despite growth recovery - ICICI Securities equitybulls.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from equitybulls.com Daily Mail and Mail on Sunday newspapers.
Thyrocare Technologies Ltd board recommends dividend of Rs 15 equitybulls.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from equitybulls.com Daily Mail and Mail on Sunday newspapers.